Cargando…
Robust induction of neutralizing antibodies against the SARS‐CoV‐2 Delta variant after homologous Spikevax or heterologous Vaxzevria‐Spikevax vaccination
Sera of vaccines were assessed by surrogate virus neutralization tests for their capacity to neutralize the SARS‐CoV‐2 Delta variant. Homologous prime‐boost immunization with Moderna's Spikevax as well as heterologous immunization with AstraZeneca's Vaxzevria followed by Moderna's Spi...
Autores principales: | Hammerschmidt, Swantje I., Thurm, Christoph, Bošnjak, Berislav, Bernhardt, Günter, Reinhold, Annegret, Willenzon, Stefanie, Ritter, Christiane, Reinhold, Dirk, Schraven, Burkhart, Förster, Reinhold |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9015245/ https://www.ncbi.nlm.nih.gov/pubmed/34870322 http://dx.doi.org/10.1002/eji.202149645 |
Ejemplares similares
-
Neutralization of the SARS-CoV-2 Delta variant after heterologous and homologous BNT162b2 or ChAdOx1 nCoV-19 vaccination
por: Hammerschmidt, Swantje I., et al.
Publicado: (2021) -
L’EMA recommande la booster dose avec Spikevax
por: Manus, Jean-Marie
Publicado: (2022) -
Homologous and Heterologous Anti-COVID-19 Vaccination Does Not Induce New-Onset Formation of Autoantibodies Typically Accompanying Lupus Erythematodes, Rheumatoid Arthritis, Celiac Disease and Antiphospholipid Syndrome
por: Thurm, Christoph, et al.
Publicado: (2022) -
Spikevax approuvé pour les 12-17 ans en Europe
por: Dalmat, Yann-Mickael
Publicado: (2021) -
Extrafollicular proliferation of B‐blasts: Morphologic correlate to Spikevax‐induced lymphadenopathy
por: Tzankov, Alexandar, et al.
Publicado: (2022)